Receptor binding, behavioral, and electrophysiological profiles of nonpeptide corticotropin-releasing factor subtype 1 receptor antagonists CRA1000 and CRA1001

Journal of Pharmacology and Experimental Therapeutics

Volumn 289, Issue 2, 1999, Pages 926-935

  Okuyama, Shigeru ^a   Chaki, Shigeyuki ^a   Kawashima, Naoya ^a   Suzuki, Yoshiko ^a   Ogawa, Shin Ichi ^a   Nakazato, Atsuro ^a   Kumagai, Toshihito ^a   Okubo, Taketoshi ^a   Tomisawa, Kazuyuki ^a  

^a TAISHO PHARMACEUTICAL CO LTD   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

2 [N (2 BROMO 4 ISOPROPYLPHENYL) N ETHYLAMINO] 4 [4 (3 FLUOROPHENYL) 1,2,3,6 TETRAHYDRO 1 PYRIDINYL] 6 METHYLPYRIMIDINE; 2 [N (2 BROMO 4 ISOPROPYLPHENYL) N ETHYLAMINO] 4 [4 (3 FLUOROPHENYL) 1,2,3,6 TETRAHYDROPYRIDIN 1 YL] 6 METHYLPYRIMIDINE; 4 [4 (3 FLUOROPHENYL) 1,2,3,6 TETRAHYDRO 1 PYRIDINYL] 2 [N ETHYL N (4 ISOPROPYL 2 METHYLTHIOPHENYL)AMINO] 6 METHYLPYRIMIDINE; [3 (2 BROMO 4 ISOPROPYLPHENYL) 5 METHYL 3H [1,2,3]TRIAZOLO[4,5 D]PYRIMIDIN 7 YL]BIS(2 METHOXYETHYL)AMINE; AMINE; BUTYL[2,5 DIMETHYL 7 (2,4,6 TRIMETHYLPHENYL) 7H PYRROLO[2,3 D]PYRIMIDIN 4 YL]ETHYLAMINE; CORTICOTROPIN RELEASING FACTOR ANTAGONIST; ETHYLAMINE; PYRIMIDINE DERIVATIVE; SC 241; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; BEHAVIOR; BINDING AFFINITY; CONFERENCE PAPER; DOSE RESPONSE; DRUG EFFECT; DRUG RECEPTOR BINDING; DRUG STRUCTURE; ELECTROPHYSIOLOGY; EMOTIONALITY; FRONTAL CORTEX; HEART; HYPOPHYSIS; LOCOMOTION; LOCUS CERULEUS; MALE; MAZE TEST; MEMBRANE BINDING; MOUSE; NONHUMAN; PASSIVE AVOIDANCE; PRIORITY JOURNAL; RAT; TASK PERFORMANCE; TRANQUILIZING ACTIVITY;

ANIMALS; ANXIETY; AVOIDANCE LEARNING; BEHAVIOR, ANIMAL; CELL MEMBRANE; ELECTROPHYSIOLOGY; EMOTIONS; LOCUS COERULEUS; MALE; MICE; MICE, INBRED ICR; MOTOR ACTIVITY; MUSCULOSKELETAL EQUILIBRIUM; OLFACTORY BULB; PYRIDINES; PYRIMIDINES; RATS; RATS, SPRAGUE-DAWLEY; RATS, WISTAR; RECEPTORS, CORTICOTROPIN-RELEASING HORMONE; SHEEP; STRESS, PSYCHOLOGICAL;

EID: 0032903413     PISSN: 00223565     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (75)

1. Adamec RE and McKay D (1993) The effects of CRF and α-helical CRF on anxiety in normal and hypophysectomized rats. J Psychopharmacol 7:346-354.
2. Arakawa S, Nakamura S, Kawashima N, Nishiike S and Okuyama S (1995) Antagonizing effects of VA-045 on reduced activity of rat locus coeruleus neurons following head injury or intravenous injection of clonidine. Life Sci 57:1803-1810.
3. Baram TZ, Chalmers DT, Chen C, Koutsoukos Y and De Souza EB (1997) The CRF1 receptor mediates the excitatory actions of corticotropin releasing factor (CRF) in the developing rat brain: In vivo evidence using a novel, selective, non-peptide CRF receptor antagonist. Brain Res 770:89-95.
4. Berridge CW and Dunn AJ (1986) Corticotropin-releasing factor elicited naloxone sensitive stress-like alterations in exploratory behavior in mice. Regul Pept 16: 83-93.
5. Berridge CW and Dunn AJ (1987) A corticotropin-releasing factor antagonist reverses the stress-induced changes of exploratory behavior in mice. Horm Behav 21:393-401.
6. Berridge CW and Dunn AJ (1989a) Restraint stress-induced changes in exploratory behavior appear to be mediated by norepinephrine-stimulated release of CRF. J Neurosci 9:3513-3521.
7. Berridge CW and Dunn AJ (1989b) CRF and restraint-stress decrease exploratory behavior in hypophysectomized mice. Pharmacol Biochem Behav 34:517-519.
8. Bradford MM (1976) A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 72:248-254.
9. Brady LS (1994) Stress, antidepressant drugs, and the locus coeruleus. Brain Res Bull 35:545-556.
10. Britton KT, Lee G, Dana R, Risch SC and Koob GF (1986a) Activating and 'anxiogenic' effects of corticotropin-releasing factor are not inhibited by blockage of the pituitary-adrenal system with dexamethasone. Life Sci 39:1281-1286.
11. Britton KT, Lee G, Vale W, Rivier J and Koob GF (1986b) Corticotropin-releasing factor (CRF) receptor antagonist blocks activating and anxiogenic actions of CRF in the rat. Brain Res 369:303-306.
12. Butler PD, Weiss JM, Stout JC and Nemeroff CB (1990) Corticotropin-releasing factor produces fear-enhancing and behavioral activating effects following infusion into the locus coeruleus. J Neurosci 10:176-183.
13. Buwalda S, De Boer SF, Van Kalkeren AA and Koolhaas JM (1997) Physiological and behavioral effects of chronic intracerebroventricular infusion of corticotropin-releasing factor in the rat. Psychoneuroendocrinology 22:297-309.
14. 1 antagonists, CRA1000 and CRA1001. Soc Neurosci Abst 24:589.
15. 1 receptor mRNA expression. J Neurosci 15:6340-6350.
16. Chen R, Lewis KA, Perrin MH and Vale WW (1993) Expression cloning of a human corticotropin-releasing factor receptor. Proc Natl Acad Sci USA 90:8967-8971.
17. 1 receptor antagonist. J Med Chem 40:1749-1754.
18. Crawley JN and Goodwin FK (1980) Preliminary report of a simple animal behavior model for the anxiolytic effects of benzodiazepines. Pharmacol Biochem Behav 13:167-170.
19. Darnell A, Bremner JD, Licinio J, Krystal J, Nemeroff CB, Owens M, Erdos J and Charnev DS (1994) CSF levels of corticotropin releasing factor in chronic posttraumatic stress disorder. Soc Neurosci Abstr 20:17.
20. Davis M (1992) The role of the amygdala in fear and anxiety. Ann Rev Neurosci 15:353-375.
21. De Souza EB (1987) Corticotropin-releasing factor receptors in the rat central nervous system: Characterization and regional distribution. J Neurosci 7:88-100.
22. De Souza EB, Insel TR, Perrin MH, Rivier J, Vale W and Kuhar MJ (1985) Corticotropin-releasing factor receptors are widely distributed within the rat central nervous system: An autoradiographic study. J Neurosci 5:3189-3203.
23. Dieterich KD, Lehnert H and De Souza EB (1997) Corticotropin-releasing factor receptors: an overview. Exp Clin Endocrinol Diabetes 105:65-82.
24. Dunn AJ and Berridge CW (1990) Physiological and behavioral responses to corticotropin-releasing factor administration: Is CRF a mediator of anxiety of stress responses? Brain Res Rev 15:71-100.
25. Ehlers C, Henriksen S, Wang M, Rivier J, Vale W and Bloom FE (1983) Corticotropin releasing factor produces increases in brain excitability and convulsive seizures in rats. Brain Res 278:332-336.
26. File SE (1991) Interactions of anxiolytic and antidepressant drugs with hormones of the hypothalamic-pituitary-adrenal axis, in Psychopharmacology of Anxiolytics and Antidepressants (File S.E. ed) pp 29-56, Pergamon Press, New York.
27. 1) receptor. Soc Neurosci Abstr 22:1546.
28. α receptors. Mol Pharmacol 50:679-686.
29. Guimaraes FS, Carobrez AP, De Aguiar JC and Graeff FG (1991) Anxiolytic effect in the elevated plus-maze of the NMDA receptor antagonist AP7 microinjected into the dorsal periaqueductal gray. Psychopharmacology 103:91-94.
30. Heinrichs SC, Merlo-Pich E, Miczek KA, Britton KT and Koob GF (1992) Corticotropin-releasing factor antagonist reduces emotionality in socially defeated rats via direct neurotropic action. Brain Res 581:190-197.
31. 2, receptors mediate anxiogeniclike behavior. Regul Pept 71:15-21.
32. Holsboer F, Von Bardeleben U, Gerken A, Stalla GK and Muller OA (1984) Blunted corticotropin and normal cortisol response to human corticotropin-releasing factor in depression. New Engl J Med 311:1127-1133.
33. Leonard M and Tuite M (1981) Anatomical, physiological, and behavioral aspects of olfactory bulbectomy in the rat. Int Rev Neurobiol 22:251-286.
34. Levine AS, Rogers B, Kneip J, Grace M and Morley JE (1983) Effect of centrally administered corticotropin-releasing factor (CRF) on multiple feeding paradigms. Neuropharmacology 22:337-339.
35. 1 receptor antisense oligodeoxynucleotide into the central nucleus of the amygdala reduced anxiety-related behavior in socially defeated rats. Regul Pept 59:229-239.
36. 2β receptor mRNAs are differentially distributed between the rat central nervous system and peripheral tissues. Endocrinology 136:4139-4142.
37. Lovenberg TW, Liaw CW, Grigoriadis DE, Clevenger W, Chalmers DT, De Souza EB and Oltersdorf T (1995a) Cloning and characterization of a functionally distinct corticotropin-releasing factor receptor subtype from rat brain. Proc Natl Acad Sci USA 92:836-840.
38. Luo Y, Kiss A, Makara G, Lolait SJ and Aguilera G (1994) Stress-specific regulation of corticotropin-releasing hormone receptor expression in the paraventricular and supraoptic nuclei of the hypothalamus in the rat. J Neuroendocrinol 6:689-696.
39. Lundkvist J, Chai Z, Teheranian R, Hasanvan H, Bartfai T, Jenck F, Widmer U and Moreau J-L (1996) A non-peptide corticotropin releasing factor receptor antagonist attenuates fever and exhibits anxiolytic-like activity. Eur J Pharmacol 309:195-200.
40. Makino S, Schulkin J, Smith MA, Pacak K, Palkovits M and Gold PW (1995) Regulation of corticotropin-releasing hormone receptor messenger ribonucleic acid in the rat brain and pituitary by glucocorticoids and stress. Endocrinology 136: 4517-4525.
41. Makino S, Takemura T, Asaba K, Nishiyama M, Takao T and Hashimoto K (1997) Differential regulation of type-1 and type-2α corticotropin-releasing hormone receptor mRNA in the hypothalamic paraventricular nucleus of the rat. Mol Brain Res 47:170-176.
42. 1 receptor antagonist. Eur J Pharmacol 323:21-26.
43. 1) receptor messenger ribonucleic acid in the paraventricular nucleus of rat hypothalamus by exogenous CRF. Endocrinology 137:4619-4626.
44. Melia K and Duman R (1991) Involvement of corticotropin-releasing factor in chronic stress regulation of the brain noradrenergic system. Proc Natl Acad Sci USA 88:8382-8386.
45. Menzaghi F, Howard RL, Heinrichs SC, Vale W, Rivier J and Koob GF (1994) Characterization of a novel and potent corticotropin-releasing factor antagonist in rats. J Pharmacol Exp Ther 269:564-572.
46. Morimoto A, Nakamori T, Morimoto K, Tan N and Murakami N (1993) The central role of corticotropin-releasing factor (CRF1-41) in psychological stress in rats. J Physiol (Lond.) 460:321-229.
47. Nakamura S (1977) Some electrophysiological properties of neurones of rat locus coeruleus. J Physiol (Lond.) 267:641-658.
48. Nemeroff CB, Owens MJ, Bissette G, Andorn AC and Stanley M (1988) Reduced corticotropin-releasing factor binding sites in the frontal cortex of suicide victims. Arch Gen Psychiatry 45:577-579.
49. Nemeroff CB, Widerlov E, Bissette G, Wallens H, Karlsson I, Eklund K, Kilts CD, Loosen PT and Vale W (1984) Elevated concentrations of CSF corticotropin-releasing factor-like immunoreactivity in depressed patients. Science 226:1342-1344.
50. Nurimoto S, Ogawa N and Ueki S (1974) Effects of psychotropic drugs on hypere-motionality of rats with bilateral ablations of the olfactory bulbs and olfactory tubercles. Jpn J Pharmacol 24:185-193.
51. Owens MJ and Nemeroff CB (1991) Physiology and pharmacology of corticotropin-releasing factor. Pharmacol Rev 43:425-473.
52. Paxinos G and Watson C (1986) The Rat Brain in Stereotaxic Coordinates, 2nd ed, Academic Press, Sydney, Australia.
53. Perrin M, Donaldson C, Chen R, Blount A, Berggren T, Bilezikjian L, Sawchenko P and Vale WW (1995) Identification of a second corticotropin-releasing factor receptor gene and characterization of a cDNA expressed in heart. Proc Natl Acad Sci USA 92:2969-2973.
54. Plotsky PM, Cunningham Jr, ET and Widmaier EP (1989) Catecholaminergic modulation of corticotropin-releasing factor and adrenocorticotropin secretion. Endocr Rev 10:437-458.
55. Potter E, Sutton S, Donaldson C, Chen R, Perrin M, Lewis K, Sawchenko PE and Vale W (1994) Distribution of corticotropin-releasing factor receptor mRNA expression in the rat brain and pituitary. Proc Natl Acad Sci USA 91:8777-8781.
56. 2 binding sites in adult rat brain. Neuropsychopharmacology 17:308-316.
57. Rassnick S, Heinrichs SC, Britton KT and Koob GF (1993) Microinjection of a corticotropin-releasing factor antagonist into the central nucleus of the amygdala reverses anxiogenic-like effects of ethanol withdrawal. Brain Res 606:25-32.
58. Rivest S, Laflamme N and Nappi RE (1995) Immune challenge and immobilization stress induce transcription of the gene encoding the CRF receptor in selective nuclei of the rat hypothamus. J Neurosci 15:2680-2695.
59. Rivier J, Rivier C and Vale W (1984) Synthetic competitive antagonists of corticotropin-releasing factor: Effects on ACTH secretion in the rat. Science 224:889-891.
60. Sarnyai Z, Biro E, Gardi J, Vecsernyes M, Julesz J and Telegdy G (1995) Brain corticotropin-releasing factor mediates 'anxiety-like' behaviour induced by cocaine withdrawal in rats. Brain Res 675:89-95.
61. Schulz DW, Mansbach RS, Sprouse J, Braselton JP, Collins J, Corman M, Dunaiskis A, Farach S, Schmidt AW, Seeger T, Seymour P, Tingley III, FD, Winston EN, Chen YL and Heym J (1996) CP-154,526: A potent and selective nonpeptide antagonist of corticotropin-releasing factor receptors. Proc Natl Acad Sci USA 93:10477-10482.
62. Sirinathsinghji DJS, Rees LH, Rivier JH and Vale W (1983) Corticotropin-releasing factor is a potent inhibitor of sexual receptivity in the female rat. Nature 305:232-235.
63. Skutella T, Montkowski A, Stohr T, Probst JC, Landgraf R, Holsboer F and Jirikowski GF (1994) Corticotropin-releasing hormone (CRF) antisense oligode-oxynucleotide treatment attenuates social defeat-induced anxiety in rats. Cell Mol Neurobiol 14:579-588.
64. Shibata S, Nakanishi H, Watanabe S and Ueki S (1984) Effects of chronic administration of antidepressants on mouse-killing behavior (muricide) in olfactory bulbectomized rats. Pharmacol Biochem Behav 21:225-230.
65. Swanson LW, Sawchenko PE, Rivier J and Vale W (1983) Organization of ovine corticotropin-releasing factor immunoreactive cells and fibers in the rat brain: An immunohistochemical study. Neuroendocrinology 36:165-186.
66. Swiergiel AH, Takahashi LK and D Kalin NH (1993) Attenuation of stress-induced behavior by antagonism of corticotropin-releasing factor receptors in the central amygdala in the rat. Brain Res 623:229-234.
67. Taylor AL and Fishman LM (1988) Corticotropin-releasing hormone. N Engl J Med 319:213-222.
68. Vale W, Spiess J, Rivier C and Rivier J (1981) Characterization of a 41 residue ovine hypothalamic peptide that stimulates secretion of corticotropin and beta endorphine. Science 213:1394-1397.
69. Valentino RJ, Foote SL and Aston-Jones G (1983) Corticotropin-releasing factor activates noradrenergic neurons of the locus coeruleus. Brain Res 270:363-367.
70. Valentino RJ and Wehby RG (1988) Corticotropin-releasing factor: evidence for a neurotransmitter role in the locus coeruleus during hemodynamic stress. Neuroendocrinology 48:674-677.
71. Van Riezen H and Leonard BE (1991) Effects of psychotropic drugs on the behavior and neurochemistry of olfactory bulbectomized rats, in Psychopharmacology of Anxiolytics and Antidepressants, (File S.E. ed) pp 231-250, Pergamon Press, New York.
72. Weiss JM, Stout JC, Aron MF, Quan N, Owens MJ, Butler PD and Nemeroff CB (1994) Depression and anxiety: Role of the locus coeruleus and corticotropin-releasing factor. Brain Res Bull 35:561-572.
73. 1 receptor antagonists. J Med Chem 39:4354-4357.
74. Wong M-L, Licinio J, Pasternak KI and Gold PW (1994) Localization of corticotropin-releasing hormone (CRH) receptor mRNA in adult rat brain by in situ hybridization histochemistry. Endocrinology 135:2275-2278.
75. Yamamoto T, Shibata S and Ueki S (1982) Effects of locus coeruleus stimulation on muricide in olfactory bulbectomized and rapha lesioned rats. Jpn J Pharmacol 32:845-853.